Update
Ashland to Expand Delaware Formulation and Contract Manufacturing
Ashland says it is expanding its contract manufacturing business in order to offer its customers greater scope in drug solubilization.
Archives for March 11, 2013
Accelovance Acquires CRO Division of Radiant Research to Expand Reach
In a move to expand its vaccine and oncology research offerings, Accelovance has acquired Radiant Development, the CRO division of Radiant Research.
For Sale: Another Merck & Co API Plant - Cost, 280 Irish Jobs
MSD says plans to shutter an Irish API facility are not part of an outsourcing strategy and intends to relocate both staff and manufacturing.
FDA Faces Uncertainty with Sequester, Continuing Resolution
The US FDA’s ability to inspect facilities, trial sites, and deal with all but its most pressing priorities will be restricted by mandatory government spending cuts according to the Alliance for a Stronger FDA.
EC says Drugmakers Have Time to Mark Risky Drugs with Black Triangle
The European Commission (EC) says timelines for new laws requiring that risky drugs are marked for extra safety monitoring take industry practicalities into account.